choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Neurocrine Biosciences Endocrinology

Neurocrine Biosciences Endocrinology Newsletter
  • Breaking Down Neurocrine Biosciences: 12 Analysts Share Their Views 05 Sep 2025 13:51 GMT

    … Neurocrine Biosciences analyst ratings. All You Need to Know About Neurocrine Biosciences Neurocrine Biosciences … treatment of neurological and endocrine-related diseases and disorders … . Understanding the Numbers: Neurocrine Biosciences's Finances Market …

  • The Analyst Verdict: Neurocrine Biosciences In The Eyes Of 17 Experts 31 Jul 2025 20:34 GMT

    … on Neurocrine Biosciences analyst ratings. Get to Know Neurocrine Biosciences Better Neurocrine Biosciences Inc … treatment of neurological and endocrine-related diseases and … capacity. Revenue Growth: Neurocrine Biosciences's remarkable performance …

  • CRF1 and CRF2 antagonists disclosed in Neurocrine Biosciences patent 10 Jul 2025 20:51 GMT

    Endocrine/;metabolic Neurocrine Biosciences Inc. has divulged cyclic peptides … hypertension, among others. BioWorld Science Endocrine/;metabolic Patents

  • Analyst Expectations For Neurocrine Biosciences's Future 02 Jun 2025 21:08 GMT

    … recent developments related to Neurocrine Biosciences. This information offers … on Neurocrine Biosciences analyst ratings. Discovering Neurocrine Biosciences: A Closer Look Neurocrine Biosciences … treatment of neurological and endocrine-related diseases and …

  • Neurocrine Biosciences To Present Wide-Ranging One-Year Data From Phase 3 Cahtalysttm Pediatric Study At Pediatric Endocrine Society 2025 Annual Meeting 16 May 2025 14:34 GMT

    … be presented at the Pediatric Endocrine Society (PES) 2025 … Prescribing Information . About Neurocrine Biosciences, Inc. Neurocrine Biosciences is a leading neuroscience … SCIENCE are registered trademarks of Neurocrine Biosciences, Inc. CRENESSITY, CAHtalyst …

  • What to Expect from Neurocrine Biosciences's Earnings 02 May 2025 21:19 GMT

    … insights regarding Neurocrine Biosciences. The consensus rating for Neurocrine Biosciences is Buy, … metrics. Discovering Neurocrine Biosciences: A Closer Look Neurocrine Biosciences Inc engages … treatment of neurological and endocrine-related diseases and …

  • Deep Dive Into Neurocrine Biosciences Stock: Analyst Perspectives (14 Ratings) 26 Mar 2025 14:53 GMT

    … Neurocrine Biosciences analyst ratings. All You Need to Know About Neurocrine Biosciences Neurocrine Biosciences … treatment of neurological and endocrine-related diseases and … to treat uterine fibroids. Neurocrine Biosciences: Delving into Financials …

  • Neurocrine Biosciences Reports Mixed Q4 07 Feb 2025 15:35 GMT

    … estimates. Neurological therapeutics specialist Neurocrine Biosciences (NBIX -13.88% … and administrative expenses Understanding Neurocrine Biosciences Neurocrine Biosciences is a biotechnology company … for neurological and endocrine-related diseases. The …

  • Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2024 Earnings Call Transcript 07 Feb 2025 13:32 GMT

    … highly engaged with the endocrinology community, conducting extensive educational … in from community endocrinologists, from endocrinologists that are part … Goodbye. Follow Neurocrine Biosciences Inc (NASDAQ:NBIX) Follow Neurocrine Biosciences Inc (NASDAQ: …

  • Endocrinolgoy Month in Review: May 2025 05 Jun 2025 00:13 GMT

    … the obesity space. In pediatric endocrinology, crinecerfont showed promise in … important updates in endocrinology from May 2025. Endocrinology Pipeline and Regulatory … Analysis On May 8, 2025, Neurocrine Biosciences announced exploratory Phase 3 CAHtalyst …

Satisfied with the content?

Continue to create your account.